AstraZeneca Sends Legal Notice to Serum Institute of India over Delays in Vaccine Supply

AstraZeneca Sends Legal Notice to Serum Institute of India over Delays in Vaccine Supply

Serum Institute of India (SII), the busiest vaccine maker in the world as measured by volume in production, apparently now is too busy.  And politics could contribute to that pace further as just recently the demand for any coronavirus vaccine in India skyrocketed due to growing numbers of SARS-CoV-2 cases and the Indian government, which placed a ban on all exports of vaccine product produced in the country. As it turns out, India is a major exporter of vaccine product to the rest of the world. The BBC reported by March 24 that India had exported 60 million doses to 76 countries, mostly as part of the World Health Organization (WHO) and the Covax facility. As a consequence of this export ban initiated late last month, BBC wrote, “Some 190 countries under the Covax scheme are likely to be affected.” A majority of vaccines now in use in India are “Covishield,” which is the AstraZeneca/Oxford vaccine made by SII and Covaxin produced by Bharat Biotech. AstraZeneca partnered with SII to produce the AZD1222 or “Oxford” vaccine, which would then be produced in India and of course distributed around the world. Now SII is in delay, and AstraZeneca has served the company with a legal notic...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee